ARCHIVES

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Anna Barker Named Deputy Director for Strategic Scientific Initiatives

December 6, 2002

Guttmacher Named NICHD Director

December 18, 2009

NTP Board Gives Concept Approvals

December 4, 1981

Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder

October 2, 1992

Cancer Control Planning Conference Delayed To 1977

August 13, 1976

Senate approves $1 billion increase for NIH; 3.7% raise is smallest since 1995.

September 19, 2003